This content is machine translated New oral therapy for ulcerative colitis First selective S1P receptor modulator in gastroenterology Ozanimod offers a new treatment option for adult patients with moderate to severe active ulcerative colitis (UC) who have had an inadequate or no response to conventional therapy or a… CME-Test
